Order Article Reprints

Mandac Smoljanović I, Aurer I, Bulj N, Dreta B, Miljak A, Petričević F, Ivić M, Bašić-Kinda S, Zatezalo V, Madunić S, et al. Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia—A KroHem Study. Cancers. 2025; 17(14):2302. https://doi.org/10.3390/cancers17142302

Mandac Smoljanović, Inga, Igor Aurer, Nikola Bulj, Barbara Dreta, Antonija Miljak, Fran Petričević, Marija Ivić, Sandra Bašić-Kinda, Viktor Zatezalo, Sanja Madunić, and et al. 2025. "Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia—A KroHem Study" Cancers 17, no. 14: 2302. https://doi.org/10.3390/cancers17142302

Mandac Smoljanović, I., Aurer, I., Bulj, N., Dreta, B., Miljak, A., Petričević, F., Ivić, M., Bašić-Kinda, S., Zatezalo, V., Madunić, S., Čaržavec, D., Sinčić-Petričević, J., Grohovac, D., Jakšić, O., Krečak, I., Morić-Perić, M., Coha, B., Berneš, P., Živković, N., & Pejša, V. (2025). Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia—A KroHem Study. Cancers, 17(14), 2302. https://doi.org/10.3390/cancers17142302